Vaccine Delivery Devices Market Report 2021-2031

Vaccine Delivery Devices Market Report 2021-2031

Vaccine Delivery Devices Market – reveals the latest trends, opportunities, predicted revenues, and competitive analysis. Read on to determine how you can exploit the impending business opportunities emerging in this sector along with detailed COVID-19 recovery scenarios.

Global vaccine delivery devices market is projected to reach a market value of US$ xx billion by 2031 with a lucrative CAGR during the forecast period. Visiongain’s report shows you the potential revenues streams to 2031, assessing the different segments, major players, qualitative analysis, opportunities trends, and business prospects in the vaccine delivery devices industry.

How this report will benefit you

Visiongain’s new study is envisioned for anyone requiring commercial in-depth analyses for the global vaccine delivery devices market along with detailed segment analysis in the market. Our new study assists you to evaluate the overall global and regional market for vaccine delivery devices. Get the financial analysis of the overall market and different segments including by device type, route of administration, usability, and end-user. High opportunity remains in this fast-growing Vaccine delivery devices market. See how to exploit the existing opportunities in the market to gain maximum advantage in the near future. In addition, the report would also help you to enhance your strategic decision making, strengthen the analysis of competitors, allows you to formulate growth strategies, and maximise the profitability of the company.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • Our new study provides you with revenue forecast by different segments including device type, route of administration, usability, and end-user to 2031
  • It also includes growth rates for different 5 regional markets along with 20 countries and COVID-19 impact analysis on each market
  • The profiles of the top 15 companies are very descriptive and comprehensive data including company snapshot, overview, commercial developments, company market shares, and detailed financial analysis with revenue and other financials
  • The COVID-19 has a positive impact on the vaccine delivery devices industry and the report includes detailed analysis and invaluable insight into how COVID-19 will affect the industry.
Discover sales forecasts for the global and regional market forecasts from 2020-2031

Along with revenue prediction for the overall global market, there is segmentation by region for 5 regional markets including North America, Europe, Asia Pacific, Latin America, and MEA and 20 major countries.

Global Vaccine Delivery Devices Market Revenue and Growth Forecasts from 2020 to 2031 By Device Type
  • Syringes
  • Jet Injectors
  • Micro Needles
  • Others
Global Vaccine Delivery Devices Market Revenue and Growth Forecasts from 2020 to 2031 By Route of Administration
  • Intramuscular
  • Subcutaneous
  • Intradermal
  • Others
Global Vaccine Delivery Devices Market Revenue and Growth Forecasts from 2020 to 2031 By Usability
  • Disposable
  • Reusable
Global Vaccine Delivery Devices Market Revenue and Growth Forecasts from 2020 to 2031 By End-User
  • Hospitals
  • Clinics
  • Others
Regional market revenue and growth forecasts from 2020 to 2031:
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA
Need industry data? Please contact us today.

Leading companies and those seeking to enter the market

The report includes profiles of 15 major companies involved in the vaccine delivery devices market. The companies profiled in this report include: F Kindeva Drug Delivery; B. Braun Medical Inc.; Becton Dickinson & Company; Corium International, Inc.; Gerresheimer AG; Hindustan Syringes & Medical Devices Limited; PharmaJet; SCHOTT AG; Smiths Medical; Terumo Corporation; Vaxxas Inc.; Gerresheimer AG; ApiJect; Verndari; Inovio Pharmaceutical Inc.; and Esperovax.

Find qualitative and quantitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

In summary, our 458 page report delivers you with the following knowledge:
  • Revenue forecasts from 2020 to 2031 for the global vaccine delivery devices market and subsegments (by device type, route of administration, usability, end-user, and region)– discover the industry’s prospects, finding the most lucrative areas for investments and revenue generation
  • Detailed profiles of top 20 vaccine delivery devices manufacturers, with financial overviews for net revenues, operating income, R&D investment, and segment revenues
  • Revenue forecasts from 2020 to 2031 for 5 regional markets – See forecasts for the vaccine delivery devices market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Information found nowhere else

With this new and exclusive report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your investment, research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the vaccine delivery devices market and detailed analysis of COVID-19 impact. You will get the most recent data, opportunities, trends, and predictions.

The Vaccine Delivery Devices Market Forecast 2020-2031 will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional market or to understand strategic analysis of leading companies of the vaccine delivery devices industry

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1. Introduction to Vaccine Delivery Devices Market
1.2. Global Vaccine Delivery Devices Market Segmentation
1.3. Why You Should Read This Report
1.4. What This Report Delivers
1.5. Key Questions Answered By This Analytical Report Include:
1.6. Who is This Report For?
1.7. Methodology
1.1.1 COVID-19 Impact: Recovery Scenarios
1.1.2 Market Evaluation & Forecasting Methodology
1.8. Frequently Asked Questions (FAQs)
1.9. Associated Visiongain Reports
1.10. About Visiongain
2 Executive Summary
3 Market Overview
3.1 Drivers
3.1.1 Growing Demand for Vaccines in Developed as well as Developing Countries
3.1.2 Technological Advancements and Introduction of Novel Vaccine Delivery Devices
3.1.3 High Demand for COVID-19 Vaccine
3.1.4 Rising Number of Product Approvals
3.2 Restraints
3.2.1 Lack of Awareness and Insufficient Supply of Vaccines in Developing Regions
3.2.2 High Cost of Vaccines
3.3 Opportunities
3.3.1 Large Amount of R&D Investment by Medical Devices Companies
3.3.2 Constant Improvements in Vaccine Technology and Delivery Methods
3.3.3 Funding For Vaccine Development Programs
3.4 Trends
3.4.1 Funding from NGOs and Government Organizations
3.4.2 Rising Immunization Programs in Developing Countries
3.4.3 Rising Adoption of Adult Vaccines
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Supplier: Moderate
3.5.2 Bargaining Power of Buyer: Moderate
3.5.3 Competitive Rivalry: High
3.5.4 Threat of New Entrants: Moderate
3.5.5 Threat of Substitutes: Low
3.6 SWOT Analysis
3.6.1 Strengths
3.6.2 Weaknesses
3.6.3 Opportunities
3.6.4 Threats
3.7 PEST Analysis
3.7.1 Political
3.7.2 Economical
3.7.3 Social
3.7.4 Technological
4 COVID Impact: Global Vaccine Delivery Devices Market 2021-2031
5 Global Vaccine Delivery Devices Market Size Forecast 2021-2031 by Device Type
5.1 Global Vaccine Delivery Devices Market Forecasts 2021-2031
5.2 Global Vaccine Delivery Devices Market: COVID-19 Recovery Forecasts (V,U, W, L) 2021-2031
5.2.1 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
5.2.2 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
5.2.3 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
5.2.4 "L" Shaped Recovery - Rapid Decline - Then Slow Growth
6 Global Vaccine Delivery Devices Market Size Forecast 2021-2031 by Device Type
6.1 Syringes Segment: Revenue Forecast 2021-2031
6.1.1 Demand for Syringes Is Increasing Due to the Growing Demand for Vaccines and Vaccination Programs
6.1.2 Recovery Scenarios for Syringes Segment, 2021-2031: (V, U, W, L)
6.2 Jet Injectors Segment: Revenue Forecast 2021-2031
6.2.1 Increased Preference for Minimal Invasive Products is Boosting the Demand for Jet Injectors
6.2.2 Jet Injectors Segment: Recovery Forecasts (V, U, W, L)
6.3 Micro Needles Segment: Revenue Forecast 2021-2031
6.3.1 Facilitate Easy Storage and Speedy Distribution through the Postal Service to Central Locations or Even to Individual Households
6.3.2 Micro Needles Segment: Recovery Forecasts (V,U, W, L)
6.4 Other Device Types Segment: Revenue Forecast 2021-2031
6.4.1 Growing Investment in R&D for Novel Vaccine Delivery Systems is Driving the Market Growth
6.4.2 Other Device Types Segment: Recovery Forecasts (V,U, W, L)
7 Global Vaccine Delivery Devices Market Size Forecast 2021-2031 by Route of Administration
7.1 Intramuscular Segment: Revenue Forecast 2021-2031
7.1.1 Intramuscular Delivery is the Largest Revenue Grossing Segment
7.1.2 Intramuscular Segment: Recovery Forecasts (V,U, W, L)
7.2 Subcutaneous Segment: Revenue Forecast 2021-2031
7.2.1 Rising Adoption of Measles, Rubella, Mumps Vaccins
7.2.2 Subcutaneous Segment: Recovery Forecasts (V,U, W, L)
7.3 Intradermal Segment: Revenue Forecast 2021-2031
7.3.1 Most Widely Used Route of Administration for BCG Vaccine
7.3.2 Intradermal Segment: Recovery Forecasts (V,U, W, L)
7.4 Other Route of Administration Segment: Revenue Forecast 2021-2031
7.4.1 Growing Demand for Advanced Route of Administration is expected to drive the Segment Growth
7.4.2 Other Route of Administration Segment: Recovery Forecasts (V,U, W, L)
8 Global Vaccine Delivery Devices Market Size Forecast 2021-2031 by Usability
8.1 Disposable Products Segment: Revenue Forecast 2021-2031
8.1.1 Disposable Vaccine Delivery Devices Held the Largest Market Share
8.1.2 Disposable Products Segment: Recovery Forecasts (V,U, W, L)
8.2 Reusable Products Segment: Revenue Forecast 2021-2031
8.2.1 Product Advancement is Projected to Drive the Segment Growth
8.2.2 Reusable Products Segment: Recovery Forecasts (V, U, W, L)
9 Global Vaccine Delivery Devices Market Size Forecast 2021-2031 by End-User
9.1 Hospitals Segment: Revenue Forecast 2021-2031
9.1.1 Hospitals Segment Accounted for the Largest Revenue Share
9.1.2 Hospitals Segment: Recovery Forecasts (V,U, W, L)
9.2 Clinics Segment: Revenue Forecast 2021-2031
9.2.1 COVID-19 Pandemic in 2020 is Expected to Boost the Segment Growth in the Near Future
9.2.2 Clinics Segment: Recovery Forecasts (V, U, W, L)
9.3 Other End-Users Segment: Revenue Forecast 2021-2031
9.3.1 Rising Adoption of Adult Vaccines and Growing Disposable Income in Developing Regions
9.3.2 Other End-Users Segment: Recovery Forecasts (V,U, W, L)
10 Regional and Leading National Vaccine Delivery Devices Market Forecasts 2021-2031
10.1 Global Vaccine Delivery Devices Market by Regional Market Forecast 2021-2031
11 North America Vaccine Delivery Devices Market
11.1 Presence of Highly Developed Healthcare Infrastructure
11.2 Rising Prevalence of Viral and Infectious Diseases
11.3 North America Vaccine Delivery Devices Market Forecast 2021-2031
11.3.1 North America Recovery Scenarios (V, U, W, L)
11.4 North America Vaccine Delivery Devices Market Forecast by Country, 2021-2031
11.4.1 North America Vaccine Delivery Devices Market Forecast by Country, 2021-2031: Recovery Scenarios (V, U, W, L)
11.5 North America Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR%)
11.5.1 North America Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031: Recovery Scenarios (V, U, W, L)
11.6 North America Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR%)
11.6.1 North America Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031: Recovery Scenarios (V, U, W, L)
11.7 North America Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR%)
11.7.1 North America Vaccine Delivery Devices Market Forecast by Usability, 2021-2031: Recovery Scenarios (V, U, W, L)
11.8 North America Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
11.8.1 North America Vaccine Delivery Devices Market Forecast by End-User, 2021-2031: Recovery Scenarios (V, U, W, L)
11.9 U.S. Vaccine Delivery Devices Market Forecast 2021-2031
11.9.1 Presence of Major Medical Device Companies in the U.S.
11.9.2 Growing Prevalence of Viral and Infectious Diseases including Influenza snd COVID-19
11.9.3 U.S. Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
11.10 Canada Vaccine Delivery Devices Market Forecast 2021-2031
11.10.1 High Investment in Drug R&D
11.10.2 Advanced Healthcare Infratructure in Canada
11.10.3 Canada Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12 Europe Vaccine Delivery Devices Market
12.1 Second-Largest Revenue-Grossing Market
12.2 Hub for Advanced Vaccine Delivery Devices Development and Manufacturing
12.3 Europe Vaccine Delivery Devices Market Forecast 2021-2031
12.3.1 Europe Vaccine Delivery Devices Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
12.4 Europe Vaccine Delivery Devices Market Forecast by Country, 2021-2031
12.4.1 Europe Vaccine Delivery Devices Market Forecast by Country, 2021-2031: Recovery Scenarios (V, U, W, L)
12.5 Europe Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR%)
12.5.1 Europe Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031: Recovery Scenarios (V, U, W, L)
12.6 Europe Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR%)
12.6.1 Europe Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031: Recovery Scenarios (V, U, W, L)
12.7 Europe Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR%)
12.7.1 Europe Vaccine Delivery Devices Market Forecast by Usability, 2021-2031: Recovery Scenarios (V, U, W, L)
12.8 Europe Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
12.8.1 Europe Vaccine Delivery Devices Market Forecast by End-User, 2021-2031: Recovery Scenarios (V, U, W, L)
12.9 Germany Vaccine Delivery Devices Market Forecast 2021-2031
12.9.1 Largest Revenue-Generating Market in Europe
12.9.2 Established Healthcare System
12.9.3 Germany Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.10 UK Vaccine Delivery Devices Market Forecast 2021-2031
12.10.1 Second-Largest Market in the Europe Region
12.10.2 Growing Adoption of Adult Vaccines
12.10.3 UK Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.11 France Vaccine Delivery Devices Market Forecast 2021-2031
12.11.1 Growing Demand for Innovative Technologies
12.11.2 Strong Public Health Insurance Program
12.11.3 France Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.12 Italy Vaccine Delivery Devices Market Forecast 2021-2031
12.12.1 Fourth Biggest Market Within the European Region
12.12.2 High Demand for COVID-19 Vaccine in Italy
12.12.3 Italy Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.13 Spain Vaccine Delivery Devices Market Forecast 2021-2031
12.13.1 Spanish Economy is Growing Strong and Returning to Economic Growth
12.13.2 Mounting Government Funding for Healthcare Infrastrcuture
12.13.3 Spain Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.14 Russia Vaccine Delivery Devices Market Forecast 2021-2031
12.14.1 Presents an Attractive Market to Expand Within the Country
12.14.2 Expected Rapid Roll-Out of the Mass Vaccination Program for COVID-19
12.14.3 Russia Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
12.15 Rest of Europe Vaccine Delivery Devices Market Forecast 2021-2031
12.15.1 Rest of Europe Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13 Asia Pacific Vaccine Delivery Devices Market
13.1 Fastest-Growing Regional Market for Vaccine Delivery Devices
13.2 Rising Incidence of Viral and Infectious Diseases in Asia Pacific
13.3 Asia Pacific Vaccine Delivery Devices Market Forecast 2021-2031
13.3.1 Asia Pacific Vaccine Delivery Devices Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
13.4 Asia Pacific Vaccine Delivery Devices Market Forecast by Country, 2021-2031
13.4.1 Asia Pacific Vaccine Delivery Devices Market Forecast by Country, 2021-2031: Recovery Scenarios (V, U, W, L)
13.5 Asia Pacific Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR%)
13.5.1 Asia Pacific Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031: Recovery Scenarios (V, U, W, L)
13.6 Asia Pacific Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR%)
13.6.1 Asia Pacific Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031: Recovery Scenarios (V, U, W, L)
13.7 Asia Pacific Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR%)
13.7.1 Asia Pacific Vaccine Delivery Devices Market Forecast by Usability, 2021-2031: Recovery Scenarios (V, U, W, L)
13.8 Asia Pacific Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
13.8.1 Asia Pacific Vaccine Delivery Devices Market Forecast by End-User, 2021-2031: Recovery Scenarios (V, U, W, L)
13.9 Japan Vaccine Delivery Devices Market Forecast 2021-2031
13.9.1 High Investment in R&D
13.9.2 Asia's Most Lucrative Medical Devices Market
13.9.3 Japan Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13.10 China Vaccine Delivery Devices Market Forecast 2021-2031
13.10.1 Fastest Growing Vaccine Delivery Devices Market
13.10.2 Increasing Incidence of Infectious and Viral Diseases
13.10.3 China Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13.11 India Vaccine Delivery Devices Market Forecast 2021-2031
13.11.1 Government Support to Strengthen the Healthcare Infrastructure
13.11.2 Mounting Focus on Immunization Programs
13.11.3 India Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13.12 Australia Vaccine Delivery Devices Market Forecast 2021-2031
13.12.1 Rising Adoption of Adult Vaccination
13.12.2 Availability of High-End Healthcare Infrastructure
13.12.3 Australia Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13.13 South Korea Vaccine Delivery Devices Market Forecast 2021-2031
13.13.1 Developing Healthcare Infrastructure
13.13.2 Rising Demand for Vaccines
13.13.3 South Korea Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
13.14 Rest of Asia Pacific Vaccine Delivery Devices Market Forecast 2021-2031
13.14.1 Rest of Asia Pacific Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
14 Latin America Vaccine Delivery Devices Market
14.1 Developing Healthcare Infrastructure
14.2 Growing Disposable Income
14.3 Latin America Vaccine Delivery Devices Market Forecast 2021-2031
14.3.1 Latin America Vaccine Delivery Devices Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
14.4 Latin America Vaccine Delivery Devices Market Forecast by Country, 2021-2031
14.4.1 Latin America Vaccine Delivery Devices Market Forecast by Country, 2021-2031: Recovery Scenarios (V, U, W, L)
14.5 Latin America Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR%)
14.5.1 Latin America Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031: Recovery Scenarios (V, U, W, L)
14.6 Latin America Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR%)
14.6.1 Latin America Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031: Recovery Scenarios (V, U, W, L)
14.7 Latin America Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR%)
14.7.1 Latin America Vaccine Delivery Devices Market Forecast by Usability, 2021-2031: Recovery Scenarios (V, U, W, L)
14.8 Latin America Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
14.8.1 Latin America Vaccine Delivery Devices Market Forecast by End-User, 2021-2031: Recovery Scenarios (V, U, W, L)
14.9 Brazil Vaccine Delivery Devices Market Forecast 2021-2031
14.9.1 Brazil Accounted for the Largest Revenue Share in Latin America
14.9.2 Government Initiatives for Better Healthcare Facilities
14.9.3 Brazil Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
14.10 Mexico Vaccine Delivery Devices Market Forecast 2021-2031
14.10.1 Lower Manufacturing Cost in Mexico
14.10.2 Rising Investment in Healthcare Infrastructure
14.10.3 Mexico Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
14.11 Argentina Vaccine Delivery Devices Market Forecast 2021-2031
14.11.1 Growing Disposable Income
14.11.2 Rising Incidence of Infectious Diseases
14.11.3 Argentina Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
14.12 Rest of Latin America Vaccine Delivery Devices Market Forecast 2021-2031
14.12.1 Rest of Latin America Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
15 MEA Vaccine Delivery Devices Market
15.1 Rising Incidence of Infectious Diseases
15.2 Demand for Advanced Healthcare Products
15.3 MEA Vaccine Delivery Devices Market Forecast 2021-2031
15.3.1 MEA Vaccine Delivery Devices Market Forecast, 2021-2031: Recovery Scenarios (V, U, W, L)
15.4 MEA Vaccine Delivery Devices Market Forecast by Country, 2021-2031
15.4.1 MEA Vaccine Delivery Devices Market Forecast by Country, 2021-2031: Recovery Scenarios (V, U, W, L)
15.5 MEA Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR%)
15.5.1 MEA Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031: Recovery Scenarios (V, U, W, L)
15.6 MEA Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR%)
15.6.1 MEA Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031: Recovery Scenarios (V, U, W, L)
15.7 MEA Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR%)
15.7.1 MEA Vaccine Delivery Devices Market Forecast by Usability, 2021-2031: Recovery Scenarios (V, U, W, L)
15.8 MEA Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR%)
15.8.1 MEA Vaccine Delivery Devices Market Forecast by End-User, 2021-2031: Recovery Scenarios (V, U, W, L)
15.9 South Africa Vaccine Delivery Devices Market Forecast 2021-2031
15.9.1 Increasing Focus of Medical Devices & Biotechnology Companies in this Region
15.9.2 High Demand for Advanced Vaccine Delivery Products
15.9.3 South Africa Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
15.10 Saudi Arabia Vaccine Delivery Devices Market Forecast 2021-2031
15.10.1 Presence of Huge Growth Opportunities in Saudi Arabia
15.10.2 Availibility of Advanced Healthcare Infrastructure
15.10.3 Saudi Arabia Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
15.11 Rest of MEA Vaccine Delivery Devices Market Forecast 2021-2031
15.11.1 Rest of MEA Vaccine Delivery Devices Market: Recovery Forecasts (V, U, W, L)
16 Leading Companies in the Vaccine Delivery Devices Market
16.1 Company Share Analysis, 2020
16.2 Kindeva Drug Delivery (Formerly 3M Drug Delivery Systems)
16.2.1 Company Snapshot, 2020
16.2.2 Company Overview
16.2.3 Financials, 2015-2019
16.2.4 Product Portfolio
16.2.5 Latest Developments, 2020
16.3 B. Braun Medical Inc.
16.3.1 Company Snapshot, 2020
16.3.2 Company Overview
16.3.3 Financials, 2015-2019
16.3.4 Product Portfolio
16.3.5 Latest Developments, 2020
16.4 Becton Dickinson & Company
16.4.1 Company Snapshot, 2020
16.4.2 Company Overview
16.4.3 Financials, 2015-2019
16.4.4 Product Portfolio
16.4.5 Latest Developments, 2020
16.5 Corium International, Inc.
16.5.1 Company Snapshot, 2020
16.5.2 Company Overview
16.5.3 Financials, 2015-2019
16.5.4 Product Portfolio
16.6 Hindustan Syringes & Medical Devices Limited
16.6.1 Company Snapshot, 2020
16.6.2 Company Overview
16.6.3 Product Portfolio
16.6.4 Latest Developments, 2020
16.7 PharmaJet
16.7.1 Company Snapshot, 2020
16.7.2 Company Overview
16.7.3 Product Portfolio
16.7.4 Latest Developments, 2020
16.8 SCHOTT AG
16.8.1 Company Snapshot, 2020
16.8.2 Company Overview
16.8.3 Financials, 2015-2019
16.8.4 Product Portfolio
16.8.5 Latest Developments, 2020
16.9 Smiths Medical
16.9.1 Company Snapshot, 2020
16.9.2 Company Overview
16.9.3 Financials, 2015-2019
16.9.4 Product Portfolio
16.9.5 Latest Developments, 2020
16.10 Terumo Corporation
16.10.1 Company Snapshot, 2020
16.10.2 Company Overview
16.10.3 Financials, 2015-2019
16.10.4 Product Portfolio
16.10.5 Latest Developments, 2020
16.11 Vaxxas Inc.
16.11.1 Company Snapshot, 2020
16.11.2 Company Overview
16.11.3 Product Portfolio
16.11.4 Latest Developments, 2020
16.12 Gerresheimer AG
16.12.1 Company Snapshot, 2020
16.12.2 Company Overview
16.12.3 Financials, 2015-2019
16.12.4 Product Portfolio
16.12.5 Latest Developments, 2020
16.13 ApiJect
16.13.1 Company Snapshot, 2020
16.13.2 Company Overview
16.13.3 Product Portfolio
16.13.4 Latest Developments, 2020
16.14 Verndari
16.14.1 Company Snapshot, 2020
16.14.2 Company Overview
16.14.3 Product Portfolio
16.14.4 Latest Developments, 2020
16.15 Inovio Pharmaceutical Inc.
16.15.1 Company Snapshot, 2020
16.15.2 Company Overview
16.15.3 Financials, 2015-2019
16.15.4 Product Portfolio
16.15.5 Latest Developments, 2020
16.16 Esperovax
16.16.1 Company Snapshot, 2020
16.16.2 Company Overview
16.16.3 Product Portfolio
16.16.4 Latest Developments, 2020
17 Conclusions and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
LIST OF TABLES
Table 1 Global Vaccine Delivery Devices Market, 2021-2031 (US$ billion, CAGR %)
Table 2 R&D Investment by Leading Players
Table 3 Global Vaccine Delivery Devices Market, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 4 “V” Shaped Recovery: Global Vaccine Delivery Devices Market, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 5 “U” Shaped Recovery: Global Vaccine Delivery Devices Market, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 6 “W” Shaped Recovery: Global Vaccine Delivery Devices Market, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 7 “L” Shaped Recovery: Global Vaccine Delivery Devices Market, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 8 Global Vaccine Delivery Devices Market Forecast by Device Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 9 Syringes Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
“V” Shaped Recovery: Syringes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 10 “U” Shaped Recovery: Syringes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 11 “W” Shaped Recovery: Syringes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 12 “L” Shaped Recovery: Syringes Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 13 Jet Injectors Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 14 “V” Shaped Recovery: Jet Injectors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 15 “U” Shaped Recovery: Jet Injectors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 16 “W” Shaped Recovery: Jet Injectors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 17 “L” Shaped Recovery: Jet Injectors Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 18 Micro Needles Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 19 “V” Shaped Recovery: Micro Needles Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 20 “U” Shaped Recovery: Micro Needles Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 21 “W” Shaped Recovery: Micro Needles Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 22 “L” Shaped Recovery: Micro Needles Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 23 Other Device Types Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 24 “V” Shaped Recovery: Other Device Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 25 “U” Shaped Recovery: Other Device Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 26 “W” Shaped Recovery: Other Device Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 27 “L” Shaped Recovery: Other Device Types Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 28 Global Vaccine Delivery Devices Market Forecast by Route of Administration, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 29 Intramuscular Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 30 “V” Shaped Recovery: Intramuscular Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 31 “U” Shaped Recovery: Intramuscular Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 32 “W” Shaped Recovery: Intramuscular Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 33 “L” Shaped Recovery: Intramuscular Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 34 Subcutaneous Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: Subcutaneous Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 39 Intradermal Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 40 “V” Shaped Recovery: Intradermal Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 41 “U” Shaped Recovery: Intradermal Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 42 “W” Shaped Recovery: Intradermal Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 43 “L” Shaped Recovery: Intradermal Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 44 Other Route of Administration Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 45 “V” Shaped Recovery: Other Route of Administration Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 46 “U” Shaped Recovery: Other Route of Administration Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 47 “W” Shaped Recovery: Other Route of Administration Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 48 “L” Shaped Recovery: Other Route of Administration Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 49 Global Vaccine Delivery Devices Market Forecast by Usability, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 50 Disposable Products Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 51 “V” Shaped Recovery: Disposable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 52 “U” Shaped Recovery: Disposable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 53 “W” Shaped Recovery: Disposable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 54 “L” Shaped Recovery: Disposable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 55 Reusable Products Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 56 “V” Shaped Recovery: Reusable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Reusable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Reusable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Reusable Products Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 60 Global Vaccine Delivery Devices Market Forecast by End-User, 2021-2031 (US$ billion, AGR %, CAGR %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings